An international team of researchers led by the Netherlands Cancer Institute developed a method to better predict the outgrowth of ductal carcinoma in situ (DCIS), a possible precursor of breast ...

Please provide your email address to receive an email when new articles are posted on . A significant number of women with non-screen-detected ductal carcinoma in situ had invasive cancer or breast ...

Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study In parallel to the sharp decline in HT use in ...

Durability of Response With Selpercatinib in Patients With RET-Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001 Ductal carcinoma in situ (DCIS) is routinely treated with ...

DCIS is a type of breast cancer that occurs when abnormal cells appear in the breast’s milk ducts. “In situ” means “in place,” so the cancer has not spread beyond the milk ducts. What are some ...

A newly released study is challenging the way doctors commonly treat patients with ductal carcinoma in situ (DCIS), known as stage zero breast cancer. DCIS cancer cells are confined inside a milk duct ...

Metaplastic breast carcinoma, a rare entity (<1% of breast neoplasms), lacks comprehensive spectroscopic characterization. This study aimed to address this gap by providing a qualitative and ...

Please provide your email address to receive an email when new articles are posted on . Results showed a lower 2-year cumulative rate of invasive ipsilateral breast cancer among patients assigned ...

The first study comparing surgery to active monitoring as treatment for ductal carcinoma in situ (DCIS) finds women who carefully monitor the precancerous cells are no more likely to develop breast ...